NCT00054964

Comparative Effectiveness of a Breath-operated Albuterol Inhaler in Asthma Patients With Poor Inhaler Technique

Comparison of Single-dose Efficacy of Albuterol-HFA-BOI and Albuterol-HFA-MDI in Asthmatics With Poor Inhaler Coordinating Ability

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 14 (actual)
• Sponsor: Teva Branded Pharmaceutical Products R&D, Inc. · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This study was designed to examine the effectiveness of a breath-operated albuterol inhaler in asthma patients who have difficulty using their standard "press-and-breathe" inhaler.

Detailed description

This was a single-center, randomized, open-label, active-controlled, 2-period, 2-sequence, single dose-dose, crossover comparison of the ability of Albuterol BOI-HFA to produce bronchodilation relative to that produced by to albuterol MDI-HFA in at least 12 asthmatics with poor inhaler coordinating ability.

Conditions

• Asthma

Interventions

Type	Name	Description
DRUG	Albuterol HFA-BOI	Albuterol HFA breath operated inhaler, 90 mcg/sprau
DRUG	Albuterol HFA-MDI	Albuterol HFA multi-dose inhaler

Timeline

• Start date: 2003-03-31
• Primary completion: 2003-08-31
• Completion: 2003-08-31
• First posted: 2003-02-17
• Last updated: 2021-11-30

Locations

1 site across 1 country: United States